Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/31/2012CN102151242B In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof
10/31/2012CN102133273B Traditional Chinese medicine lipid-lowing and catharsis capsule and preparation method thereof
10/31/2012CN102133212B Asarone medical composition
10/31/2012CN102120012B Compound preparation comprising American ginseng and alpinia oxyphylla
10/31/2012CN102077928B Tilapia immune potentiator and preparation method thereof
10/31/2012CN102038858B Preparation method of Chinese herbal composition with effects of invigorating Qi and nourishing blood
10/31/2012CN102038775B Preparation method of traditional Chinese medicine composition for treating cold in children
10/31/2012CN102018665B Strictosamide injection and preparation method thereof
10/31/2012CN101983703B Traditional Chinese medicine composition and traditional Chinese medicine preparation
10/31/2012CN101972395B Calming and decompressing traditional Chinese medicine composition and preparation method thereof
10/31/2012CN101961495B Plant soft capsule material and preparation method thereof
10/31/2012CN101959514B Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder
10/31/2012CN101933976B Method for preparing nanoemulsion from high-efficient active sites of fructus forsythiae essential oil
10/31/2012CN101926784B Electric hydrogel sticking agent for instantaneous pulse electric field transdermal drug administration and preparation method thereof
10/31/2012CN101890049B Pediatric paracetamol oral solution formula and preparation method thereof
10/31/2012CN101879250B Arthralgia relief gel paste and preparation method
10/31/2012CN101874811B Preparation method of silica modified nano pearl powder
10/31/2012CN101827578B Inverted vesicles
10/31/2012CN101758961B Patch package structure
10/31/2012CN101703728B Quality detection method for stomach warming and soothing capsules
10/31/2012CN101590105B Chinese medicinal herb extract for inducing immune cells to generate interferon and activated TOLL-like receptors and preparation method thereof
10/31/2012CN101534952B Method of micronization
10/31/2012CN101448486B A composition for inactivating an enveloped virus
10/31/2012CN101411747B Salvia root polyphenol acid orally disintegrating tablets and preparation method thereof
10/31/2012CN101360483B Biologically active composition comprising ethylcellulose
10/31/2012CN101278936B Clear eye lotion containing latanoprost as effective ingredient
10/31/2012CN101257890B Argatroban formulation comprising an acid as solubilizer
10/31/2012CN101137395B Pharmaceutical composition containing hardly water soluble medicament
10/31/2012CN101081245B Medicine for treating cardiovascular and cerebrovascular diseases
10/31/2012CN101023947B Methods and compositions for bactericide, bacteriostatic and anti-inflammation
10/30/2012US8299178 Stable micelles formed with diblock copolymers of critical micelle concentration copolymer and temperature-sensitive copolymer
10/30/2012US8299121 Softgel of NLKJ for treating prostate diseases
10/30/2012US8299052 Pharmaceutical compositions and methods for improved bacterial eradication
10/30/2012US8298607 Method for electrostatic coating of a medical device
10/30/2012US8298585 Cellulose-based fine core particle and process for producing the same
10/30/2012US8298583 Film delivery system for tetrahydrolipstatin
10/30/2012US8298582 Polysaccharide-based impregnated solid material with improved stability, processes for the preparation thereof and impregnating solutions used
10/30/2012US8298581 Matrix compositions for controlled delivery of drug substances
10/30/2012US8298580 Sustained-release formulations of topiramate
10/30/2012US8298579 Tamper resistant dosage form comprising an adsorbent and an adverse agent
10/30/2012US8298577 Effervescent oral opiate dosage forms and methods of administering opiates
10/30/2012US8298576 Sustained-release formulations of topiramate
10/30/2012US8298575 consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but improve usability of filled capsules with regard to function, longevity, and/or the geographic location of their use
10/30/2012US8298574 Method and apparatus for forming delivery devices for oral intake of an agent
10/30/2012US8298573 Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
10/30/2012US8298572 Adhesive pharmaceutical preparation containing bisoprolol
10/30/2012US8298570 Sustained release intraocular implants and related methods
10/30/2012US8298569 Ophthalmic emulsions containing an immunosuppressive agent
10/30/2012US8298568 Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
10/30/2012US8298562 Sustained delivery of an active agent using an implantable system
10/30/2012US8298561 Rapid establishment and/or termination of substantial steady-state drug delivery
10/30/2012US8298560 Methods and compositions for repair of cartilage using an in vivo bioreactor
10/30/2012US8298559 Physical mode of action pesticide
10/30/2012US8298554 Stable pharmaceutical composition and methods of using same
10/30/2012US8298553 Personal care composition
10/30/2012US8298530 Stable lyophilized pharmaceutical formulation of IgG antibodies
10/30/2012US8298521 Treatment for eye disorder
10/30/2012US8298520 Deodorant particle
10/30/2012US8298515 Vitamin formulation
10/30/2012US8298176 Flow-induced delivery from a drug mass
10/30/2012CA2684402C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
10/30/2012CA2669355C Guggulphospholipid methods and compositions
10/30/2012CA2620380C Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
10/30/2012CA2561660C Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/30/2012CA2549642C Effervescent oral opiate dosage forms and methods of administering opiates
10/30/2012CA2529818C Stabilised solid drug dispersions in an organic carrier and a process for preparing the same
10/30/2012CA2528460C Magnetic nanoparticles
10/30/2012CA2516449C Bioadhesive liquid composition which is substantially free of water
10/30/2012CA2512454C Ultrasound contrast agents and process for the preparation thereof
10/30/2012CA2466437C Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
10/30/2012CA2461873C Systems, methods and apparatuses for manufacturing dosage forms
10/30/2012CA2456732C Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor
10/30/2012CA2452074C Surface treatment composition for soft substrates
10/26/2012WO2012145491A2 Composition and method for enhancing an immune response
10/26/2012WO2012145470A2 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/26/2012WO2012145460A2 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/26/2012WO2012145428A2 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid
10/26/2012WO2012145355A1 Vaccine delivery method
10/26/2012WO2012144964A1 Thiocolchicoside, diclofenac and lansoprazole combinations
10/26/2012WO2012144943A1 Liquid carrier for oral delivery of a pharmacologically active agent
10/26/2012WO2012144789A2 Non-animal soft capsule shell composition having improved disintegration and shell hardness
10/26/2012WO2012144716A1 Nanoparticle-based vaccine delivery system having double functions of imaging and delivery
10/26/2012WO2012144698A1 Foam type hair dying agent composition
10/26/2012WO2012144678A1 Drug delivery composition containing biocompatible cross-linked hyaluronic acid product
10/26/2012WO2012144613A1 Method for producing complex crystal and method for screening complex crystal
10/26/2012WO2012144592A1 Solid pharmaceutical composition
10/26/2012WO2012144579A1 Antibody preparation having solution form
10/26/2012WO2012144519A1 Granules in liquid dosage form
10/26/2012WO2012144446A1 Drug delivery particles and method for producing same
10/26/2012WO2012144405A1 Method for producing adhesive patch, and adhesive patch
10/26/2012WO2012144287A1 Adhesive tape packaging bag
10/26/2012WO2012143876A1 A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
10/26/2012WO2012143875A1 Method of preparation of chitin and active principles complexes and the so obtained complexes
10/26/2012WO2012143868A1 Suspension type topical formulations comprising cyclic depsipeptide
10/26/2012WO2012143492A1 Beadlets comprising carotenoids
10/26/2012WO2012143486A1 Antigenic formulation
10/26/2012WO2012143133A1 Method for producing pharmaceutical products from a melt material
10/26/2012WO2012143013A1 Improved wound care product
10/26/2012WO2012143011A1 Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice
10/26/2012WO2012143008A1 Reduction of the level of free phosphorus compounds in the digestive juice
1 ... 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 ... 2991